» Articles » PMID: 9057842

Effect of Phosphorylated Rat Fetuin on the Growth of Hepatocytes in Primary Culture in the Presence of Human Hepatocyte-growth Factor. Evidence That Phosphorylated Fetuin is a Natural Modulator of Hepatocyte-growth Factor

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 1997 Feb 1
PMID 9057842
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Rat fetuin, a counterpart of human alpha 2-HS glycoprotein and bovine fetuin, that is synthesized and secreted by hepatocytes is mostly phosphorylated, though rat fetuin isolated from bone matrix does not contain phosphorus. A rat 63-kDa phosphorylated N-glycoprotein (pp63) is the phosphorylated form of rat fetuin and pp63 has been shown to inhibit insulin-receptor tyrosine kinase activity. Therefore, we examined the effect of phosphorylated rat fetuin (phosphofetuin) on DNA synthesis in rat hepatocytes in culture in the presence of human hepatocyte-growth factor (HGF), since the human receptor of HGF, c-Met, is known to contain a tyrosine-kinase domain in its intracellular domain. We found that phosphofetuin from conditioned medium of rat-hepatocyte cultures dose-dependently decreased HGF-stimulated DNA synthesis in hepatocytes, whereas addition of non-phosphorylated rat fetuin had no effect. Addition of anti-(rat fetuin) Ig to the culture medium increased HGF-stimulated DNA synthesis by hepatocytes. Immunoprecipitation and cross-linking experiments showed that phosphofetuin bound to human HGF. We found that phosphofetuin interfered with binding of HGF to its specific receptor(s). These observations suggest that phosphofetuin synthesized by hepatocytes may be a natural modulator of HGF as a chalone, and that regulation of expression of phosphofetuin by growth factors and cytokines may be involved in liver regeneration under inflammatory conditions, such as in hepatitis.

Citing Articles

Post-translational modifications glycosylation and phosphorylation of the major hepatic plasma protein fetuin-A are associated with CNS inflammation in children.

Ricken F, Can A, Graber S, Hausler M, Jahnen-Dechent W PLoS One. 2022; 17(10):e0268592.

PMID: 36206263 PMC: 9544022. DOI: 10.1371/journal.pone.0268592.


Tissue chaperoning-the expanded functions of fetuin-A beyond inhibition of systemic calcification.

Rudloff S, Jahnen-Dechent W, Huynh-Do U Pflugers Arch. 2022; 474(8):949-962.

PMID: 35403906 PMC: 8995415. DOI: 10.1007/s00424-022-02688-6.


Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response.

Harris V, Bell L, Langan R, Tuddenham J, Landy M, Sadiq S PLoS One. 2017; 12(4):e0175575.

PMID: 28388685 PMC: 5384772. DOI: 10.1371/journal.pone.0175575.


Concentrations of fetuin-A, osteoprotegerin and α-Klotho in patients with alcoholic liver cirrhosis.

Prystupa A, Dabrowska A, Sak J, Tarach J, Torun-Jurkowska A, Lachowska-Kotowska P Exp Ther Med. 2016; 12(5):3464-3470.

PMID: 27882180 PMC: 5103841. DOI: 10.3892/etm.2016.3754.


Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells.

Siegel-Axel D, Ullrich S, Stefan N, Rittig K, Gerst F, Klingler C Diabetologia. 2014; 57(5):1057-66.

PMID: 24493202 DOI: 10.1007/s00125-014-3177-0.